Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-522-0 | CAS number: 61-90-5
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
No test results for L-leucine are available. However, read-across to the test results available for structural analogue L-valine is deemed justified based on a comparison of the main factors driving skin sensitisation: the chemical reactivity (functional groups) of the substance and its tendency to undergo dermal absorption, which in itself is determined by the substance's molecular weight, log Kow and water solubility.
- both are essential amino acids that are in the zwitterion state at physiological pH
- the chemical structure differs only in that L-leucine has one extra methylene group in the aliphatic side chain
- both amino acids are quite small molecules with a low MW (LEU: 131 g/mol, VAL: 117 g/mol), which favors dermal uptake, however
- both amino acids have log Kow values below -1 (LEU: -1.52, VAL: -2.26) which suggests that these substances are most likely not sufficiently lipophilic to cross the stratum corneum
- the water solubility of leucine and valine is high (LEU: 23 g/L, VAL: 58 g/L). In combination with a low log Kow, it can be assumed that these substances will be too hydrophilic to cross the lipid rich environment of the stratum corneum. As a consequence, dermal uptake will be low.
As the chemical reactivity and the dermal uptake of L-leucine and L-valine are almost identical, it can be concluded that read-across of skin sensitisation information between those 2 substances is acceptable.
The tests available for L-valine are carried out according to OECD guidelines and reveal no effects of skin sensitisation. L-valine was concluded to not be sensitising to the skin. As a consequence, skin sensitisation effects are not expected to occur upon exposure to L-leucine.
Migrated from Short description of key information:
No test results for L-leucine are available. However, based on test results available for read-across substance L-valine it can be concluded that skin sensitisation is not expected upon exposure to L-leucine.
Justification for classification or non-classification
In accordance to Directive 67/548/EEC (Dangerous Substances Directive), classification is not necessary for skin sensitisation based on the available test data for read-across substance L-valine.
In accordance to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008, classification is not necessary for skin sensitisation based on the available test data for read-across substance L-valine.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
